Study on the Use Effectiveness of the Norepinefrina and Serotonin Reuptake Inhibitors in the Obesity Treatment (Sibutramine®)

  • Luciano Ferreira Ferreira Centro Universitário de Maringá – CESUMAR
  • Elenice Gomes Gomes Centro Universitário de Maringá – CESUMAR
Keywords: Obesity, Treatment, Sibutramine.

Abstract

The obesity is a chronic illness where its prevalence is growing up during the decades. For this reason, it has become diversified the weight reduction treatment mainly in the pharmacologic utilization. So the objective of this research in to evaluate the effectiveness of sibutramine hydrochloride monohydrate in pharmacologic therapy anti-obesity from two to four months. It has been analyzed 487 patient’s dossier who submitted themselves in the pharmacologic treatment for loss of weight in 2003. It had been selected patients that had used sibutramine in its treatment and subsequently distributed in two groups (sibutramine and sibutramine+fluoxetine), that it was composed for 41 and 21 patients, respectively. In agreement the treatment time we can observe that the sibutramine presented an average weight loss of 4,9Kg, 6,6Kg and 9,6Kg in 2, 3 and 4 months respectively, 3,3Kg, 3,6Kg, and 1,7Kg in sibutramine plus fluoxetine groups among 2, 3 and 4 months. In consequence the IMC showed with a proportional reduction, but the difference the IMC of the two groups enter when comparing our results with other studies we can conclude that the sibutramine showed efficiency in the obesity treatment.

Author Biographies

Luciano Ferreira Ferreira, Centro Universitário de Maringá – CESUMAR
Enfermeiro Graduado pelo Centro Universitário de Maringá – CESUMAR. E-mail: hp.luciano@gmail.com
Elenice Gomes Gomes, Centro Universitário de Maringá – CESUMAR
Docente Mestre do Departamento de Fisioterapia do Centro Universitário de Maringá – CESUMAR. E-mail: elenicegomes@gmail.com
Published
2009-10-08
Section
Artigos Originais